Page 61 - 2023 Taiwan Food and Drug Administration Annual Report
P. 61

Reinforced Management over Controlled                                                            4
       Drugs and Prevention Against Drug
                                                 Abuse

▍	Achievements and Benefits                      took place on October 18, 2022. US DEA
                                                 Supervisor Jennifer Jimenez, UCLA Professor
I. Added/Revised controlled                      Yih-Ing Hser, and many other domestic
  drugs and active                               experts and scholars were invited to exchange
  pharmaceutical ingredients                     with one another and share what they knew
  included in control                            about the management of controlled drugs in
                                                 Taiwan and the US and the use of controlled
      The Ministry of Health and Welfare         drugs for medical purpose, among others.
convened the 45th and 46th Controlled Drugs
Review Committee meeting in 2022 to add          Section 2
a total of 311 items of controlled drugs and
APIs.                                            Advancement
                                                 in the Quality of
II. Implemented project-                         Schedule 1 and 2
   based audits and enhanced                     Controlled Drugs
   knowledge and skills of
   healthcare professionals in                   ▍	Introduction of the Policy
   the use of controlled drugs
                                                       In 2020, multiple R&D projects
      The audit project was enforced for         commenced at TFDA’s pharmaceutical factory
controlled drugs in 2022; a total of 188         (hereinafter referred to as the Factory) for
companies were inspected and 37 were             controlled drugs with the aim of enhancing
found with violations, with a violation rate of  product quality and expanding capacity. The
19.68%. Meanwhile, the “Pain Care Reference      plan is to produce products that are currently
Handbook for Patients on Palliative Care” and    outsourced or imported from other countries
the “Pain Care Reference Handbook for Non-       independently. Renovated workshops were
cancer Patients with Suspected Substance         also completed and commissioned in 2021
Use Disorders” were prepared in addition         to fulfill the goal of local manufacturing
to a total of 6 sessions of online educational   of essential drugs and ensuring a sufficient
training. Knowledge and skills of healthcare     supply.
professionals on the use of controlled drugs in
patients were enhanced to prevent iatrogenic
addiction. In addition, the “2022 U.S.-Taiwan
Web Conference on Controlled Drugs”

                                                                                                 59
   56   57   58   59   60   61   62   63   64   65   66